MCC
BBC icon

Money Concepts Capital’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Money Concepts Capital’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-370
Closed -$9.25K – 670
2022
Q4 		$9.25K Buy
+370
New +$9.21K ﹤0.01% 2051
2022
Q2 		– Sell
-220
Closed -$6K – 1530
2022
Q1 		$6K Buy
+220
New +$6.51K ﹤0.01% 2109

Other funds holding BBC

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Money Concepts Capital's BBC Position: Q1 2023 in Review

Money Concepts Capital sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2023, closing a stake of 370 shares — an estimated $9.25K sold.

Money Concepts Capital first reported a position in BBC in Q1 2022 and held it in 2 quarters. The position peaked at $9.25K in Q4 2022. 16 funds tracked by Wall St. Rank hold BBC as of Q1 2023.

  • Money Concepts Capital reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 370 Virtus Biotech Clinical Trials ETF shares in Q1 2023, an estimated $9.25K.
  • Money Concepts Capital first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Virtus Biotech Clinical Trials ETF position peaked at $9.25K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.